ANIP

Ani Pharmaceutic

• TipRanks·4d ago

  J.P. Morgan Reaffirms Their Buy Rating on ANI Pharmaceuticals (ANIP)

• TipRanks·10/19 11:00

  ANI Pharmaceuticals launches Duloxetine Delayed-Release Capsules

• Benzinga·10/19 10:57

  ANI Pharmaceuticals Launches Duloxetine Delayed-Release Capsules 20, 30 And 60 Mg, Generic Version Of Reference Listed Drug Cymbalta

• NASDAQ·10/13 11:55

  These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar

• Seeking Alpha·10/12 15:37

  ANI Pharma reports positive phase 4 data for Iluvien in non-infectious uveitis

• NASDAQ·10/12 11:46

  ANI Pharmaceuticals Report Two-Year Vision Improvements In Phase 4 Eye Disease Study

• TipRanks·10/12 11:00

  ANI Pharmaceuticals reports ‘positive’ results from Phase 4 Synchronicity trial

• TipRanks·10/06 15:00

  Analysts Offer Insights on Healthcare Companies: Stryker (SYK) and ANI Pharmaceuticals (ANIP)

• Seeking Alpha·09/24 16:15

  ANI Pharmaceuticals: Cortrophin's Q4 Test, With Generics Funding The Build

• Dow Jones·09/23 12:13

  ANI Pharmaceuticals Price Target Announced at $85.00/Share by Oppenheimer

• Benzinga·09/23 12:03

  Oppenheimer Initiates Coverage On ANI Pharmaceuticals with Perform Rating, Announces Price Target of $85

• NASDAQ·09/23 11:48

  ANI Pharmaceuticals Wins FDA Approval For Generic Everolimus Tablets For Oral Suspension

• NASDAQ·09/23 11:20

  FDA Approves ANI Pharma's Generic Everolimus Tablets

• TipRanks·09/23 11:05

  ANI receives FDA approval for its ANDA for Everolimus Tablets

• Benzinga·09/23 10:56

  ANI Pharmaceuticals Receives Final FDA Approval Of Its Abbreviated New Drug Application For Everolimus Tablets For Oral Suspension